knowledge -WSS

knowledge

author：entertainment 2025-10-02 12:41:55 - browse：22

green electrocardiogram scan. -- health tech coverage from STAT — Adobe

As Bristol Myers Squibb works to build its treatment for a heart condition that can cause difficulty breathing into a blockbuster drug, it’s propped up an algorithm designed to help find more people who are affected.

The algorithm, which is part of software developed by Viz.ai, earlier this month received clearance from the Food and Drug Administration. The tool, called Viz HCM, looks at 12-lead electrocardiograms collected during routine care and flags suspected cases of hypertrophic cardiomyopathy, or HCM, for further evaluation. As part of a multi-year agreement between the companies, BMS — whose drug, Camzyos, is used to treat HCM — provided funding and scientific input for the development of the algorithm.

“BMS has a vested interest in finding more patients with HCM,” said Matthew Martinez, a cardiologist who leads Viz.ai’s HCM medical advisory board. “Why? Because they’re so philanthropic? No, they want to sell more drugs. They want to help more people by identifying more people.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： YouTube cracks down on misinformation on cancer treatment

knowledge

WSS

Biden administration begins canceling student loan debt for 804,000 borrowers

After Optum profits sink, UnitedHealth makes changes

Congressmen charge Covid hearing ‘could have been an email’

Medicare drug price negotiation’s day in court

Do digital therapeutics have a future in medicine?

What to know about the judge who will handle the Trump case

entertainment

knowledge

knowledge

Medicare proposal to cover medical devices draws a mixed reaction

Woodcock on FDA’s accelerated approval and her next chapter

Walensky prepares to leave CDC — and Congress — behind

Idaho college killings prosecutors challenge defense's grand jury claims

Wildfire smoke exposes gaps in outdoor worker protections

The real point of Kenneth Smith’s execution by nitrogen gas

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Quicker fix for pulse oximeters urged during FDA public meeting

Duchenne breakthrough therapy leaves behind pioneering families

FDA drug safety: Singulair case shows systemic surveillance flaws

entertainment

Medicare drug price negotiation’s day in court

Judge sides with young activists in first

Schizophrenia gene found to be linked to cells' energy dysfunction

Congressmen charge Covid hearing ‘could have been an email’

Sweeping indictment could be Trump's biggest legal challenge yet: ANALYSIS

Megan Rapinoe shares emotional post following US Women's World Cup exit

focus

knowledge

focus

explore